SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-063604
Filing Date
2021-05-10
Accepted
2021-05-10 11:33:56
Documents
5
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm2114348d2_def14a.htm DEF 14A 429732
2 GRAPHIC tm2114348d2img_002.jpg GRAPHIC 4905
3 GRAPHIC tm2114348d2img_005.jpg GRAPHIC 250786
4 GRAPHIC tm2114348d2img_004.jpg GRAPHIC 102646
5 GRAPHIC tm2114348d2_def14aimg001.jpg GRAPHIC 4447
  Complete submission text file 0001104659-21-063604.txt   931086
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-20713 | Film No.: 21905770
SIC: 2836 Biological Products, (No Diagnostic Substances)